ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
ThirtyFiveBio's investors include AbbVie, Canaan Partners, Innovate UK, Mayewell Capital.
ThirtyFiveBio is headquartered in Abingdon, United Kingdom.
ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
ThirtyFiveBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ThirtyFiveBio — Funding & Investors." VCBacked, April 15, 2025, https://www.vcbacked.co/company/thirtyfivebio. Accessed September 30, 2026.
VCBacked. (2025). ThirtyFiveBio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/thirtyfivebio
{{cite web |title=ThirtyFiveBio — Funding & Investors |url=https://www.vcbacked.co/company/thirtyfivebio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated